IBD Biomed develops biomedical devices for dialysis and non-invasive lung ventilation, focusing on making them economically accessible.

IBD Biomed

Amplifon provides hearing healthcare services and products, self-described as a global leader in the field.

Amplifon

Bracco is involved in the healthcare sector, focusing on diagnostic imaging technologies and solutions to improve patient outcomes.

Bracco

Diasorin is a specialist in molecular diagnostics and immunodiagnostics, providing technologies to detect physiological markers and diseases in human samples. Self-described as active in the Licensed Technology sector.

Diasorin

IBD Italian Biomedical Devices | 1,449 followers on LinkedIn. IBD looks at reverse Innovation of biomedical devices as key to make quality healthcare affordable for the most. | IBD is an innovative SME, a biomedical devices manufacturer company conceived in London and founded in Italy in 2014.

Guided by a team with +10 years of experience in medical device design, IBD has raised so far over € 1 million in funding from angel investors and grants.

We rely on reverse innovation of medical devices to solve healthcare issues.

Founder and Chief Executive Officer at IBD Ltd

Corrado Ghidini

Responsable R&D and co-founder presso IBD-Italian Biomedical Devices

Andrea visotti

Ingegnere ricerca e sviluppo presso Italian Biomedical Devices Srl

Alan Fabbri

Biomedical Engineer at Health Science and Technologies ICIR - University of Bologna

Claudia Perazzini

IBD Italian Biomedical Devices

🌍 Reverse Innovation: Making Quality Accessible to All 🌍 At IBD, we believe that Reverse Innovation is the key to making quality healthcare available worldwide. 🔄 What is Reverse Innovation? Imagine having a new idea for a medical device that can help people in remote places where resources are limited. This idea, conceived to solve a problem in one location, can then be used in more advanced countries as well. That's what we do with reverse innovation: we start with the needs of resource-limited areas to create solutions that can then be adopted everywhere. 💡 Why is it Important to Us? Simplicity and Effectiveness: We create products that solve real problems in a simple and effective way. Accessibility: We make healthcare more accessible, improving people's lives everywhere. Global Innovation: The solutions we develop can help both developing and advanced countries. 🚀 Our Goal Our aim is to use Reverse Innovation to improve everyone's health by creating technologies that are useful and easy to use anywhere in the world. 🔗 Learn more about IBD on our website. To learn more about how reverse innovation is changing the future of healthcare, visit our website or contact us ➡️ info@ibdbiomed.it #MyDial #Telemedicine #DialysisCare #PatientQualityOfLife #HealthcareCostSavings #HealthcareInnovation #Telehealth #PatientCare #ibd #BiomedicalDevices #ItalianBiomedicalDevices #Biomedical #ReverseInnovation

🌟 Meet Our Team of Excellence 🌟 Claudia Paci , Biomedical Engineer and Quality and Regulatory Specialist 🔬👩🔬 Although she has been with us for just over a year and a half, Claudia has already established herself as a rising star in our team. With solid research experience at the Institute of BioRobotics of the Scuola Superiore Sant'Anna, she has demonstrated great talent in the field of biomedicine. Throughout her career, Claudia has already received significant recognitions, such as the 2022 Donne Sanminiatesi Award, which honors women from San Miniato who distinguish themselves in their professional or social fields, becoming a reference point for the local community, and the Best Master's Thesis Award from the National Bioengineering Group. 🏅 Thanks to her dedication and achievements, Claudia contributes passionately to the continuous improvement of our projects and drives innovation forward! 🚀 To learn more about our team and how we work, visit our website or contact us today ➡️ info@ibdbiomed.it #MyDial #Telemedicine #DialysisCare #PatientQualityOfLife #HealthcareCostSavings #HealthcareInnovation #Telehealth #PatientCare #ibd #BiomedicalDevices #ItalianBiomedicalDevices #Biomedical #ReverseInnovation

The Importance of Home Dialysis: Why Choose It? 🏡 Many studies have shown that home treatments improve survival rates and quality of life compared to patients who undergo dialysis in hospitals. ✨ Benefits for Patients: Home treatment allows patients to manage dialysis in a familiar environment, reducing stress and frequent travel. Additionally, it has a smaller impact on work and leisure time. Often, many patients, including young ones, have to give up work because it is incompatible with the organization of dialysis centers, or avoid going on vacation due to concerns about the availability of centers or managing access. Moreover, it encourages independence, patient autonomy, and responsibility, and increases self-confidence and trust in their caregivers.💪🏻 👩⚕️ Assistance and Support: Patients receive support from qualified healthcare personnel to manage dialysis sessions, including needle insertion and general treatment supervision. 💰 Cost Reduction: Reducing costs associated with transportation and frequent hospitalizations, which represent a significant portion of dialysis healthcare expenses, contributes to containing overall healthcare costs. 🖥️ Safe Technologies: Our modern equipment is safe and easy to use, with advanced telemedicine systems ensuring continuous monitoring and optimal clinical outcomes. Discover how this option can make a difference. 🔗 Learn more about IBD on our website. Contact us today for more information. ➡️ info@ibdbiomed.it #MyDial #Telemedicine #DialysisCare #PatientQualityOfLife #HealthcareCostSavings #HealthcareInnovation #Telehealth #PatientCare #ibd #BiomedicalDevices #ItalianBiomedicalDevices #Biomedical #ReverseInnovation

🌟 Meet Our Team of Excellence 🌟 Today, we introduce you to another key member of our team: Alan Fabbri , Biomedical Engineer in Research and Development. 🔬👨🔬 Alan is a highly qualified engineer, graduate with honors in biomedical engineering. His experience in research and development at IBD is crucial for the innovation and evolution of our medical devices. 🧪 To learn more about our team and how we work, visit our website or contact us today ➡️ info@ibdbiomed.it #MyDial #Telemedicine #DialysisCare #PatientQualityOfLife #HealthcareCostSavings #HealthcareInnovation #Telehealth #PatientCare #ibd #BiomedicalDevices #ItalianBiomedicalDevices #Biomedical #ReverseInnovation

Global Hemodialysis Statistics: A Focus on MyDial Discover key numbers and how MyDial can make a difference. 🌍 In Europe, there are 358,000 patients undergoing dialysis treatment, with 89% receiving hemodialysis. Out of these, 95% receive treatment in dialysis centers and the remaining 5% at home. 💸 €21 billion per year is the total expenditure for hemodialysis treatment in public and private centers. 💸 €60,000 is the average cost for treating a patient with end-stage renal disease. 🌍 In the USA, there are 500,000 patients undergoing dialysis treatment, with 89% receiving hemodialysis. Out off these, 99% receive treatment in dialysis centers and the remaining 1% at home. 💸 $42 billion per year is the total expenditure for hemodialysis treatment in public and private centers. 💸 $89,000 is the average cost for treating a patient with end-stage renal disease. 💡 Why MyDial Makes a Difference: With MyDial, we aim to transform hemodialysis treatment by offering a more practical and sustainable alternative. Less expensive and more accessible, it allows patients to manage their care at home, reducing costs and improving quality of life. Discover how MyDial can optimize treatment and alleviate the economic burden for patients and healthcare systems. Visit our website or contact us today for more information ➡️ info@ibdbiomed.it #MyDial #Telemedicine #DialysisCare #PatientQualityOfLife #HealthcareCostSavings #HealthcareInnovation #Telehealth #PatientCare #ibd #BiomedicalDevices #ItalianBiomedicalDevices #Biomedical #ReverseInnovation

MyDial up close: Its Main Features 📏 Compact and Lightweight: Dimensions: 40 x 38 x 32 cm Weight: 18 kg 📱 Touch-Screen Monitor: Intuitive interface. 🛠️ Easy to Install: No structural modifications required. 👍 Easy to Use: Can be used independently at home with the support of a caregiver. 🩸 Blood Flow: Up to 500 ml/min. 💊 Bicarbonate Dialysis Therapy: Customizable to suit the patient's various metabolic and purifying needs. 💧 Dialysate Flow: Up to 500 ml/min. 💰 Low-Cost Disposables: Easy to connect. MyDial means giving patients the power to decide when and where to undergo treatment, allowing them to live without the fear of being a burden to friends and family. It means empowering them to see dialysis as an integrated part of their life, not the center of it. Contact us today for more information ➡️ info@ibdbiomed.it #MyDial #Telemedicine #DialysisCare #PatientQualityOfLife #HealthcareCostSavings #HealthcareInnovation #Telehealth #PatientCare #ibd #BiomedicalDevices #ItalianBiomedicalDevices #Biomedical #ReverseInnovation

🌟 Meet the innovators behind IBD. 🌟 Founded in 2014 by Corrado Ghidini and Andrea Visotti with the goal of creating products that meet the most sophisticated technical requirements demanded by doctors and healthcare professionals. 🏥 The Founders: 👨⚕️ Corrado Ghidini Co-founder, CEO, and CFO Doctor of Medicine (MD) with a specialization in Internal Medicine 💉 Dr. Ghidini is an experienced leader in Reverse Innovation applied to biomedical devices. With a solid background in business strategies, he has designed and developed groundbreaking devices in the fields of non-invasive lung ventilation and hemodialysis. He was an associate researcher at the Bologna University Hospital, with over 70 scientific publications and a specialization in internal medicine. 👨⚕️ Andrea Visotti Co-founder and Head of R&D Biomedical Engineer 🧪 With over 10 years of experience at IBD, Andrea has in-depth expertise in the biomedical field. He is an active member of the Italian Civil Protection and was involved in emergencies such as the Abruzzo (2009) and the Emilia-Romagna (2012) earthquakes. His humanitarian commitment and dedication to research and development are the beating heart ❤️ of our company. Visit our website to learn about our products and innovative solutions or contact us today for more information. ➡️ info@ibdbiomed.it #MyDial #Telemedicine #DialysisCare #PatientQualityOfLife #HealthcareCostSavings #HealthcareInnovation #Telehealth #PatientCare #ibd #BiomedicalDevices #ItalianBiomedicalDevices #Biomedical #ReverseInnovation

What is Home Hemodialysis? 🏠 It is a treatment modality for chronic kidney disease that allows patients to perform dialysis directly at home, with all the necessary assistance. 🩺 This practice represents an effective and safe alternative to dialysis performed in hospital centers, without compromising the quality of care. It offers significant benefits in terms of quality of life and economic sustainability. 🌟 According to the National Association of Nephrology Patients – ANED, there are 50,000 patients on dialysis in Italy, representing about 0.08% of the population. Healthcare spending on dialysis amounts to 2.1% of the total expense covered by the National Health Service (SSN). Read the full article here: https://lnkd.in/dmwR3c7V Thanks to assistance programs and the use of advanced technologies, this practice is set to become increasingly widespread and accessible. Learn more about home hemodialysis and how it can make a difference in patients' lives. 🌿 Contact us today for more information ➡️ info@ibdbiomed.it #MyDial #Telemedicine #DialysisCare #PatientQualityOfLife #HealthcareCostSavings #HealthcareInnovation #Telehealth #PatientCare #ibd #BiomedicalDevices #ItalianBiomedicalDevices #Biomedical #ReverseInnovation

Italian quality at the heart of biomedicine! 🟢⚪🔴 All our biomedical devices are 100% Made in Italy. Each product is designed and developed by a team of highly qualified engineers committed to ensure the highest quality and innovation. Our dedication to precision and attention to details is reflected in every phase of the production process, ensuring reliable and cutting-edge solutions for the healthcare sector. Discover the future of biomedicine with us! Visit our website to learn about our products and innovative solutions or contact us today for more information. ➡️ info@ibdbiomed.it #MyDial #Telemedicine #DialysisCare #PatientQualityOfLife #HealthcareCostSavings #HealthcareInnovation #Telehealth #PatientCare #ibd #BiomedicalDevices #ItalianBiomedicalDevices #Biomedical

MyDial, the new portable hemodialysis system, has a wide range of applications: 🏡 Home care: Thanks to its easy installation and use, MyDial allows treatments to be carried out safely within the domestic environment. 🏥 Small satellite centers: Their unique cost and size features, along with the minimal training required, improve the quality of service provided and the financial efficiency of the centers. 🌍 Developing countries: The cost reduction in devices, disposable materials, and maintenance can enable access to care for those who previously had no alternatives to survive. Offer your patients a better future with MyDial. Visit our website to learn more or contact us today for more information. ➡️ info@ibdbiomed.it #MyDial #Telemedicine #DialysisCare #PatientQualityOfLife #HealthcareCostSavings #HealthcareInnovation #Telehealth #PatientCare #ibd #BiomedicalDevices #ItalianBiomedicalDevices #Biomedical

Metric
Company Name	IBD Biomed	Amplifon	Bracco	Diasorin
Symbol
MSH ID	COM:IBDBIOMED	COM:AMPLIFON	COM:BRACCO	COM:DIASORIN:INT
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical Devices	Medical Devices	Medical Technology	Medical Diagnostics
Country	IT	IT	IT	IT
Stage
Employee Count
Website	ibdbiomed.com	amplifon.com	bracco.com	int.diasorin.com
LinkedIn	ibd-biomed	amplifon		diasorin
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	46
Web Traffic Growth	4.50
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:IBDBIOMED

IBD Biomed

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue